I have an ankle‑brachial index of 1.0 and no leg symptoms; what does this indicate and what management or follow‑up is recommended given my cardiovascular risk factors (e.g., hypertension, hyperlipidaemia, diabetes, smoking)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ABI of 1.0 in an Asymptomatic Patient with Cardiovascular Risk Factors

An ankle-brachial index of 1.0 is technically within the normal range (0.91–1.40), but in the context of multiple cardiovascular risk factors—especially diabetes—you should not rely on this single measurement alone and must obtain a toe-brachial index (TBI) to rule out masked peripheral arterial disease from arterial calcification. 1

Understanding Your ABI Value

Your ABI of 1.0 falls into what the American Heart Association considers a "borderline" zone (0.91–0.99), which warrants additional evaluation rather than simple reassurance. 1 While values between 0.91 and 1.40 are traditionally labeled "normal," the optimal cardiovascular risk range is actually 1.11–1.40, and your value sits below this. 1

Critical Limitation in High-Risk Patients

The most important caveat: if you have diabetes, your ABI of 1.0 is unreliable and potentially falsely reassuring. 1, 2 Medial arterial calcification (Mönckeberg sclerosis) is highly prevalent in diabetic patients and causes arteries to become stiff and non-compressible, producing falsely normal or even elevated ABI readings despite significant underlying stenotic disease. 1, 3 Research demonstrates that up to 50% of patients with ABI >1.40 have coexisting peripheral arterial disease that the ABI completely misses. 3

Mandatory Next Steps

For Patients with Diabetes

You must obtain a toe-brachial index immediately, regardless of your ABI result. 1, 4 The American College of Cardiology and American Heart Association recommend TBI in all diabetic patients because digital arteries are rarely affected by medial calcification, making TBI far more reliable than ABI. 1

  • TBI <0.70–0.75 confirms peripheral arterial disease 1, 4
  • TBI should be performed even when ABI appears normal because arterial calcification can mask significant ischemia 1

For Patients with Other Risk Factors (Hypertension, Hyperlipidemia, Smoking)

Even without diabetes, your constellation of cardiovascular risk factors places you at elevated risk for both peripheral arterial disease and cardiovascular events. 5, 6

If you develop any exertional leg symptoms in the future—even with your current ABI of 1.0—you require exercise treadmill ABI testing. 1 A post-exercise ankle pressure decrease >30 mmHg or ABI decrease >20% confirms PAD even when resting ABI appears normal. 1

Cardiovascular Risk Management

Your ABI of 1.0, while not diagnostic of PAD, still identifies you as someone requiring aggressive cardiovascular risk factor modification. 5 The relationship between ABI and cardiovascular outcomes follows a reverse J-shaped curve, with the lowest mortality risk in the 1.11–1.40 range. 1 Your value of 1.0 places you outside this optimal zone.

Mandatory Interventions

The American Heart Association and American College of Cardiology recommend the following for patients with your risk profile: 5, 4

  • Statin therapy to achieve LDL-C <55 mg/dL or at least 50% reduction 7
  • Smoking cessation support if currently smoking (smoking is independently associated with low ABI) 5
  • Blood pressure control (hypertension is independently associated with PAD, with adjusted odds ratio 3.20) 6
  • Glycemic control if diabetic 4
  • Consider antiplatelet therapy (low-dose aspirin or clopidogrel) for cardiovascular risk reduction 4, 7

Follow-Up Protocol

Annual ABI Surveillance

You should have bilateral ABI measurements repeated annually given your borderline value and cardiovascular risk factors. 1 The American Heart Association emphasizes that PAD may not progress symmetrically in both limbs, so both legs must be measured at each visit. 5

When to Escalate Testing

Proceed immediately to additional vascular testing if: 1, 4

  • You develop any exertional leg symptoms (claudication, leg fatigue)
  • You develop non-healing wounds on your feet or legs
  • Your ABI drops to ≤0.90 on follow-up measurement
  • Your ABI rises to >1.40 (indicating arterial calcification)
  • You have diabetes and have not yet had TBI measured

Common Pitfalls to Avoid

Never assume peripheral arterial disease is absent based solely on a single resting ABI measurement of 1.0, especially if you have diabetes. 1 The sensitivity of ABI is significantly lower in diabetic patients compared to the general population, particularly when neuropathy or chronic kidney disease coexist. 1

Never rely on palpable pulses alone—even skilled examiners can detect pulses despite significant ischemia. 4

Never delay obtaining TBI if you are diabetic—a normal ABI in diabetes does not reliably exclude PAD and requires additional vascular testing. 1

Summary Algorithm

  1. If diabetic: Obtain TBI immediately regardless of ABI result 1
  2. If non-diabetic with multiple risk factors: Implement aggressive cardiovascular risk reduction and annual ABI surveillance 5, 1
  3. If any exertional leg symptoms develop: Obtain exercise ABI testing 1
  4. If ABI drops to ≤0.90 or rises to >1.40 on follow-up: Proceed to duplex ultrasound or other anatomic imaging 1, 7

Your ABI of 1.0 is not a "free pass"—it represents a borderline finding in the context of significant cardiovascular risk factors that demands both additional testing (especially if diabetic) and aggressive risk factor modification to prevent future cardiovascular events and limb complications.

References

Guideline

Ankle-Brachial Index Values and Peripheral Arterial Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use and utility of ankle brachial index in patients with diabetes.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2011

Guideline

Vascular Assessment and Management of Heel Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Peripheral Arterial Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management approach for a patient with an Ankle-Brachial Index (ABI) of 0.56, a non-healing wound, diabetes mellitus, and hypertension?
What does a noncompressible result on one side of an Ankle-Brachial Index (ABI) test indicate?
What is the interpretation of the Ankle-Brachial Index (ABI) and recommended management for a patient with elevated ankle blood pressure, painful varicose veins, and hypertension?
What is the next step in managing a patient with a non-healing ulcer on the medial aspect of the left leg, bilateral (B/L) lower extremity varicose veins, hyperpigmentation, and easily palpable dorsalis pedis and posterior tibial pulses?
How should I measure the ankle‑brachial index at bedside in an older patient with type 2 diabetes mellitus, hypertension, hyperlipidemia, chronic limb‑threatening ischemia and a smoking history, given the risk of non‑compressible tibial arteries and the possible need for toe‑brachial index confirmation?
What is the first-line antibiotic regimen for an otherwise healthy adult with uncomplicated cystitis and no β‑lactam allergy?
Can hydromorphone extended‑release be started while a palliative care patient is already on a fentanyl transdermal patch?
Does earlier antibiotic treatment for confirmed or suspected group A streptococcal pharyngitis decrease the patient’s contagious period?
For a patient aged 6 years or older with ADHD, how do Azstarys (serdexmethylphenidate/dexmethylphenidate) and Vyvanse (lisdexamfetamine) compare in terms of FDA approval, dosing regimens, duration of effect, safety profile, and abuse potential?
Is macrobid (nitrofurantoin) safe for treating an uncomplicated urinary tract infection in a pregnant woman during the first trimester, assuming no G6PD deficiency, normal renal function, and no hypersensitivity?
What is the maximum topical dose of ketoprofen cream and the recommended dosing interval?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.